We have established the San Diego Clinical and Translafional Research Institute (San Diego CTRI), with its hublocated at the University of California, San Diego (UCSD). This regional center contains two universities (UCSDand San Diego State University), 4 biomedical research institutes (Salk Inst., Burnham Inst., J. Craig Venter Inst.,and La Jolla Inst, for Allergy and Immunology), and 3 academic hospitals (UCSD Medical Center, VA Hospitaland Rady Children's Hospital), one community health service (Palomar Pomerado Health) and 2 specializedresources~the San Diego Supercomputer Center and the California Inst, for Telecommunications andInformation Technology. The CTSA program encompasses 3 health sciences professional schools (Medicine,Pharmacy, Nursing), nine clinical research PhD programs, and a Masters program in Advanced Clinical Studies.The program goals are to: 1) Provide an academic home for the discipline of clinical and translafional science; 2)Establish an integrated educational pipeline to train and support clinical and translational scienfists; 3) Develop arobust clinical research infrastructure that replaces silos with integrated research; 4) Enhance bioinformaticscapabilities that leverage unique UCSD resources; 5) Develop novel technologies to improve research such asbiomarker and imaging; 6) Form a Translational Research Alliance with research institutes and industry; 7) Forma Community Alliance with community physicians and the general public to translate scientific discoveries intobest practices, increase research into health care disparities, and involve the general public in biomedicalscience. The CTSA program will provide the resources to develop the discipline of clinical and translationalresearch. Through the San Diego CTRI, the educational pipeline to train the next generation of clinical andtranslafional scientists will be enhanced. A new K12 program, an expanded K30 program, and the integration ofnew PhD graduate programs in clinical research highlight the proposed educational plan. The CTRI will transformeducation in clinical and translational science by coordinating disparate programs, providing breadth of educationfrom high school through pre-doctoral students and providing training to post-doctoral fellows and faculty. TheInstitute will also transform the conduct of clinical research by providing guidance and support from initialplanning through data analysis and sharing. The new structure will foster development of novel technologies tofacilitate clinical research and provide support for the services and resources necessary to conduct clinicalinvestigation. We will place special emphasis on several areas of strength such as imaging, biomarkers,community outreach, and the translation of basic science discoveries to clinical science.

Public Health Relevance

The San Diego Clinical Translational Research Institute will transform the clinical research by providing guidanceand support from initial planning through data analysis and sharing. It will provide an educafional pipeline to trainthe next generation of clinical and translafional scientists and involve the community in setting the direction andpriorities of the organization. The Institute will foster development of novel technologies that facilitate clinicalresearch, and provide support for the services needed to conduct clinical investigation and improve health.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Linked Training Award (TL1)
Project #
5TL1RR031979-02
Application #
8102117
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Merchant, Carol
Project Start
2010-07-01
Project End
2015-03-31
Budget Start
2011-04-01
Budget End
2012-03-31
Support Year
2
Fiscal Year
2011
Total Cost
$424,166
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Nguyen, Nghia H; McCormack, Shelley A; Vutien, Philip et al. (2015) Meta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirin. Intervirology 58:27-34
Evans, Christopher S; Smith, Sunny; Kobayashi, Leslie et al. (2015) The Effect of Community Health Center (CHC) Density on Preventable Hospital Admissions in Medicaid and Uninsured Patients. J Health Care Poor Underserved 26:839-51
Rojas, Steven M; Smith, Sunny D; Rojas, Sarah et al. (2015) Longitudinal hyperlipidemia outcomes at three student-run free clinic sites. Fam Med 47:309-14
Raju, Sharat C; Hauff, Samantha J; Lemieux, Aaron J et al. (2015) Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncol 51:470-5
Goldenberg, Alina; Ortiz, Arisa; Kim, Silvia S et al. (2015) Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors. J Am Acad Dermatol 73:120-6
Boland, Brigid S; Boyle, David L; Sandborn, William J et al. (2015) Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease. Inflamm Bowel Dis 21:323-30
Raju, Sharat; Vazirnia, Aria; Totri, Christine et al. (2014) Treatment of Merkel cell carcinoma of the head and neck: a systematic review. Dermatol Surg 40:1273-83
Karris, Maile Y; Kao, Yu-ting; Patel, Derek et al. (2014) Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS 28:841-9
Yee, Brittany E; Nguyen, Nghia H; Zhang, Bing et al. (2014) Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. Eur J Gastroenterol Hepatol 26:1189-201
Hauff, Samantha J; Raju, Sharat C; Orosco, Ryan K et al. (2014) Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg 151:612-8

Showing the most recent 10 out of 21 publications